| Application no. and date | 16734150.2 (espacenet) (Federated) (European Patent Register), 20160623 | | Patent/reg. no. and date | DK/EP 3313402, 20231227 | | Publication date | 20180502 | | Priority no. and date | US 201562183519 P, 20150623, US 201562183520 P, 20150623, US 201562183525 P, 20150623, US 201562183530 P, 20150623, US 201562248797 P, 20151030, US 201562248803 P, 20151030, US 201562251007 P, 20151104, US 201562251009 P, 20151104, US 201562251023 P, 20151104, US 201562251019 P, 20151104, US 201562251018 P, 20151104, US 201562251012 P, 20151104, US 201562262860 P, 20151203, US 201562262856 P, 20151203, US 201662290839 P, 20160203, US 201662290864 P, 20160203 | | EP pub. no. and date |
EP 3313402 20180502 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130-1102, US | | Applicant ref. no. | | | Inventor | O'BRIEN, Christopher, F., 12780 El Camino Real
San Diego, California 92130-1102, US,
GRIGORIADIS, Dimitri E., 12780 El Camino Real
San Diego, California 92130-1102, US | | Representative | | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61P 25/18 (2006.01) | | Title | VMAT2 INHIBITORS FOR TREATING NEUROLOGICAL DISEASES OR DISORDERS | | Int. application no. | US2016039098 | | Int. publication no. | WO2016210180 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
